View Archive »
About The Cover
The cover for issue 63 of Oncotarget features Figure 3, "GSEA value of “ECM-Receptor Interaction” pathway in high-SI6/low-SI26 and low-SI6/high-SI26 patient sub-cohorts," by Meucci, et al.
|
|
Table of Contents
Research Papers: Immunology
|
| Itaconic acid indicates cellular but not systemic immune system activation |
|
https://doi.org/10.18632/oncotarget.25956
|
| 32098-32107 |
Research Papers
|
| A nomogram prediction for the survival of patients with triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.24964
|
| 32108-32118 |
|
| Discovery of DEBIC to correlate Pselectin inhibition and DNA intercalation in cancer therapy and complicated thrombosis |
|
https://doi.org/10.18632/oncotarget.23151
|
| 32119-32133 |
|
| Pumilio2 regulates synaptic plasticity via translational repression of synaptic receptors in mice |
|
https://doi.org/10.18632/oncotarget.24345
|
| 32134-32148 |
|
| Identification of key pathways and genes in response to trastuzumab treatment in breast cancer using bioinformatics analysis |
|
https://doi.org/10.18632/oncotarget.24605
|
| 32149-32160 |
|
| Somatic genome alterations in relation to age in lung squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25848
|
| 32161-32172 |
|
| Metastases risk in thin cutaneous melanoma: prognostic value of clinicalpathologic characteristics and mutation profile |
|
https://doi.org/10.18632/oncotarget.25864
|
| 32173-32181 |
|
| Sonoporation by microbubbles as gene therapy approach against liver cancer |
|
https://doi.org/10.18632/oncotarget.25875
|
| 32182-32190 |
|
| 3D hydrogel breast cancer models for studying the effects of hypoxia on epithelial to mesenchymal transition |
|
https://doi.org/10.18632/oncotarget.25891
|
| 32191-32203 |
|
| FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis |
|
https://doi.org/10.18632/oncotarget.25941
|
| 32204-32218 |
|
| Abnormal regulation of BCR signalling by cCbl in chronic lymphocytic leukaemia |
|
https://doi.org/10.18632/oncotarget.25951
|
| 32219-32231 |
|
| Accelerated BRAF mutation analysis using a fully automated PCR platform improves the management of patients with metastatic melanoma |
|
https://doi.org/10.18632/oncotarget.25957
|
| 32232-32237 |
|
| Prognostic significance of six clinicopathological features for biochemical recurrence after radical prostatectomy: a systematic review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.22459
|
| 32238-32249 |
|
| No associations between fruit and vegetable consumption and pancreatic cancer risk: a metaanalysis of prospective studies |
|
https://doi.org/10.18632/oncotarget.23128
|
| 32250-32261 |
|
| Treatmentrelated toxicities of apatinib in solid tumors: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.24215
|
| 32262-32270 |
Corrections
|
| Correction: Immunogenicity of mammary tumor cells can be induced by shikonin via direct bindinginterference with hnRNPA1 |
|
https://doi.org/10.18632/oncotarget.26007
|
| 32271-32271 |
|
| Correction: CM363 a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia |
|
https://doi.org/10.18632/oncotarget.26008
|
| 32272-32272 |
|
| Correction: Systematic review and metaanalysis comparing zoledronic acid administered at 12week and 4week intervals in patients with bone metastasis |
|
https://doi.org/10.18632/oncotarget.26009
|
| 32273-32273 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
